HNRNPA2B1 and breast carcinoma: Previous studies have shown that HNRNPA2B1 is overexpressed in breast cancer tissue, and that its encoded protein can activate the STAT3 and ERK1/2 signaling pathways, thereby promoting the tumorigenic potential of cancer cells.